Patents by Inventor Shannon Brankley

Shannon Brankley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND PROBES FOR DETECTING ESOPHAGEAL CANCER
    Publication number: 20120141991
    Abstract: Probe sets and methods of using probes and probe sets for selectively detecting high grade dysplasia and esophageal adenocarcinoma or low grade dysplasia from biologic samples are described. Methods of the invention include contacting a biological sample obtained from a subject with a set of chromosomal probes to selectively detect an esophageal carcinoma or precursor lesion in the sample, if any, under conditions for specifically hybridizing the probes to their nucleic targets present in the sample. The presence or absence of high grade dysplasia and esophageal adenocarcinoma or low grade dysplasia is thereafter specifically determined from the hybridization pattern detected for the set of chromosomal probes to the biological sample.
    Type: Application
    Filed: October 7, 2011
    Publication date: June 7, 2012
    Inventors: Kevin Halling, Larry E. Morrison, Shannon Brankley
  • Methods and probes for detecting esophageal cancer
    Patent number: 8034577
    Abstract: Probe sets and methods of using probes and probe sets for selectively detecting high grade dysplasia and esophageal adenocarcinoma or low grade dysplasia from biologic samples are described. Methods of the invention include contacting a biological sample obtained from a subject with a set of chromosomal probes to selectively detect an esophageal carcinoma or precursor lesion in the sample, if any, under conditions for specifically hybridizing the probes to their nucleic targets present in the sample. The presence or absence of high grade dysplasia and esophageal adenocarcinoma or low grade dysplasia is thereafter specifically determined from the hybridization pattern detected for the set of chromosomal probes to the biological sample.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: October 11, 2011
    Assignees: Mayo Foundation for Medical Education and Research, Abbott Laboratories, Inc.
    Inventors: Kevin Halling, Larry E. Morrison, Shannon Brankley
  • Methods and probes for detecting esophageal cancer
    Publication number: 20060211019
    Abstract: Probe sets and methods of using probes and probe sets for selectively detecting high grade dysplasia and esophageal adenocarcinoma or low grade dysplasia from biologic samples are described. Methods of the invention include contacting a biological sample obtained from a subject with a set of chromosomal probes to selectively detect an esophageal carcinoma or precursor lesion in the sample, if any, under conditions for specifically hybridizing the probes to their nucleic targets present in the sample. The presence or absence of high grade dysplasia and esophageal adenocarcinoma or low grade dysplasia is thereafter specifically determined from the hybridization pattern detected for the set of chromosomal probes to the biological sample.
    Type: Application
    Filed: February 17, 2006
    Publication date: September 21, 2006
    Inventors: Kevin Halling, Larry Morrison, Shannon Brankley